TipRanks
Go Ultimate55% OFF

Xtant Medical Holdings (XMS) Stock Forecast & Price Target

See the Price Targets and Ratings of:

XMS Analyst Ratings

Strong Buy
3Ratings
3Buy0Hold0Sell
Based on 3 analysts giving stock ratings to Xtant Medical Holdings in the past 3 months

XMS Stock 12 Month Forecast

EUR 0.92▲(265.93% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Xtant Medical Holdings in the last 3 months. The average price target is EUR 0.92 with a high forecast of EUR 1.34 and a low forecast of EUR 0.54. The average price target represents a 265.93% change from the last price of EUR 0.25.
Highest Price TargetEUR 1.34Average Price TargetEUR 0.92Lowest Price TargetEUR 0.54

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:XMS
Price TargetFollowArticle
Lucid CapitalEUR 0.89buy254.13%UpsideInitiated09/02/26
Maxim GroupEUR 0.85→EUR 1.34buy431.19%UpsideReiterated08/28/26
Craig-HallumEUR 1.07→EUR 0.54buy112.48%UpsideAssigned08/12/26
BTIGEUR 1.34→EUR 0.89buy254.13%UpsideReiterated03/31/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OVIDOvid Therapeutics
REPLReplimune Group
IMUXImmunic
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Xtant Medical Holdings

3 Months
Success Rate11/24 ratings generated profit
46%
Average Return
+4.41%

Copying Chase Knickerbocker's trades and holding each position for 3 Months would result in 45.83% of your transactions generating a profit, with an average return of +4.41% per trade.

1 Year
Success Rate7/24 ratings generated profit
29%
Average Return
-16.23%

Copying Chase Knickerbocker's trades and holding each position for 1 Year would result in 29.17% of your transactions generating a profit, with an average return of -16.23% per trade.

2 Years
Success Rate0/24 ratings generated profit
0%
Average Return
-41.68%

Copying Chase Knickerbocker's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -41.68% per trade.

XMS Analyst Recommendation Trends

02468Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for XMS
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy13441
Buy10000
Hold00000
Sell00000
Strong Sell00000
total23441

In the current month, XMS has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. XMS average Analyst price target in the past 3 months is 0.92.

XMS Financial Forecast

EUR -2EUR -1.25EUR -0.5EUR 0.25EUR 1Q3 2025Q2 2026Q3 2026
HighEUR -0.02
ConsensusEUR -0.02
LowEUR -0.03

XMS Earnings Forecast

Next quarter’s earnings estimate for XMS is -EUR 0.02 with a range of -EUR 0.03 to -EUR 0.02. The previous quarter’s EPS was -EUR 0.06. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

EUR 18MEUR 21.2MEUR 24.3MEUR 27.4MEUR 30.6MQ3 2025Q2 2026Q3 2026
HighEUR 23M
ConsensusEUR 22M
LowEUR 20.6M

XMS Sales Forecast

Next quarter’s sales forecast for XMS is EUR 22.01M with a range of EUR 20.64M to EUR 22.98M. The previous quarter’s sales results were EUR 19.89M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

XMS Stock Forecast FAQ

What is DE:XMS’s average 12-month price target, according to analysts?
Based on analyst ratings, Xtant Medical Holdings’s 12-month average price target is €0.92.
What is DE:XMS’s upside potential, based on the analysts’ average price target?
Xtant Medical Holdings has 265.93% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Xtant Medical Holdings a Buy, Sell or Hold?
Xtant Medical Holdings has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Xtant Medical Holdings’s share price target?
The average share price target for Xtant Medical Holdings is €0.92. This is based on 3 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €1.34, and the lowest forecast is €0.54. The average share price target represents a 265.93% increase from the current price of €0.252.
What do analysts say about Xtant Medical Holdings?
Xtant Medical Holdings’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of Xtant Medical Holdings?
To buy shares of DE:XMS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.